Commerce Bank Alnylam Pharmaceuticals, Inc. Transaction History

Commerce Bank

$16.1 Billion
Q3 2024

A detailed history of Commerce Bank transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Commerce Bank holds 4,522 shares of ALNY stock, worth $1.17 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

4,522

Previous 4,617 2.06%

Holding current value

$1.17 Million

Previous $1.12 Million 10.88%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$233.81 - $287.01 $22,211 - $27,265	-95 Reduced 2.06%	4,522 $1.24 Million
Q2 2024 Aug 12, 2024	SELL	$143.31 - $247.0 $5,589 - $9,633	-39 Reduced 0.84%	4,617 $1.12 Million
Q1 2024 May 03, 2024	SELL	$146.51 - $198.2 $3,955 - $5,351	-27 Reduced 0.58%	4,656 $695,000
Q4 2023 Feb 09, 2024	BUY	$151.41 - $196.57 $11,658 - $15,135	77 Added 1.67%	4,683 $896,000
Q3 2023 Nov 13, 2023	BUY	$170.77 - $211.65 $4,781 - $5,926	28 Added 0.61%	4,606 $815,000
Q2 2023 Aug 08, 2023	SELL	$185.01 - $212.05 $5,550 - $6,361	-30 Reduced 0.65%	4,578 $869,000
Q1 2023 May 04, 2023	BUY	$182.66 - $235.53 $28,860 - $37,213	158 Added 3.55%	4,608 $923,000
Q4 2022 Feb 10, 2023	SELL	$185.53 - $241.31 $5,009 - $6,515	-27 Reduced 0.6%	4,450 $1.06 Million
Q3 2022 Nov 04, 2022	SELL	$138.54 - $232.0 $2.79 Million - $4.68 Million	-20,170 Reduced 81.84%	4,477 $896,000
Q2 2022 Aug 12, 2022	BUY	$120.42 - $169.29 $2.44 Million - $3.43 Million	20,289 Added 465.56%	24,647 $3.6 Million
Q1 2022 May 09, 2022	BUY	$127.18 - $173.91 $12,718 - $17,391	100 Added 2.35%	4,358 $712,000
Q4 2021 Feb 14, 2022	BUY	$159.56 - $209.29 $3,350 - $4,395	21 Added 0.5%	4,258 $722,000
Q3 2021 Nov 09, 2021	SELL	$169.75 - $207.73 $272,279 - $333,198	-1,604 Reduced 27.46%	4,237 $800,000
Q2 2021 Aug 09, 2021	BUY	$128.63 - $176.89 $6,817 - $9,375	53 Added 0.92%	5,841 $990,000
Q1 2021 May 05, 2021	SELL	$126.83 - $175.69 $4.29 Million - $5.94 Million	-33,798 Reduced 85.38%	5,788 $817,000
Q4 2020 Feb 09, 2021	BUY	$122.97 - $147.0 $621,121 - $742,497	5,051 Added 14.63%	39,586 $5.15 Million
Q3 2020 Nov 06, 2020	BUY	$121.19 - $165.49 $395,927 - $540,655	3,267 Added 10.45%	34,535 $5.03 Million
Q2 2020 Aug 07, 2020	BUY	$104.21 - $156.44 $2.79 Million - $4.19 Million	26,788 Added 597.95%	31,268 $4.63 Million
Q1 2020 May 08, 2020	BUY	$93.12 - $133.99 $129,436 - $186,246	1,390 Added 44.98%	4,480 $488,000
Q4 2019 Feb 14, 2020	BUY	$74.51 - $124.23 $230,235 - $383,870	3,090 New	3,090 $356,000

Others Institutions Holding ALNY

# of Institutions

639

Shares Held

108M

Call Options Held

1.15M

Put Options Held

1.07M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $31.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerce Bank, based on Form 13F filings with the SEC.

News

Stay updated on Commerce Bank with notifications on news.

Account